|
|
|
Insider
Information: |
Skolnick Phil |
Relationship: |
Chief Scientific Officer |
City: |
Hackensack |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
6
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
-40.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Opiant Pharmaceuticals Inc |
OPNT |
Chief Scientific Officer |
2023-03-02 |
0 |
2018-10-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-01-02 |
4 |
AS |
$13.84 |
$107,509 |
D/D |
(7,768) |
2,232 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-09-03 |
4 |
AS |
$14.08 |
$105,684 |
D/D |
(7,506) |
2,494 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-11-04 |
4 |
AS |
$15.28 |
$4,569 |
D/D |
(299) |
2,500 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-02-01 |
4 |
AS |
$15.32 |
$113,996 |
D/D |
(7,441) |
2,559 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-10-01 |
4 |
AS |
$14.79 |
$107,804 |
D/D |
(7,289) |
2,711 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-11-01 |
4 |
AS |
$15.10 |
$108,735 |
D/D |
(7,201) |
2,799 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-12-03 |
4 |
AS |
$13.93 |
$63,772 |
D/D |
(4,578) |
2,857 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2018-12-03 |
4 |
AS |
$15.85 |
$20,700 |
D/D |
(1,306) |
3,015 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2018-10-02 |
4 |
AS |
$17.24 |
$24,705 |
D/D |
(1,433) |
3,345 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2020-01-07 |
4 |
AS |
$13.36 |
$80,094 |
D/D |
(5,943) |
4,150 |
0 |
% |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2018-12-03 |
4 |
OE |
$9.00 |
$38,889 |
D/D |
4,321 |
4,321 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2018-10-02 |
4 |
OE |
$9.00 |
$43,002 |
D/D |
4,778 |
4,778 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2020-01-08 |
4 |
AS |
$13.46 |
$38,253 |
D/D |
(2,842) |
7,193 |
0 |
% |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-12-02 |
4 |
AS |
$14.17 |
$36,346 |
D/D |
(2,565) |
7,435 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2020-01-06 |
4 |
AS |
$13.80 |
$7,107 |
D/D |
(515) |
8,785 |
0 |
% |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2020-01-02 |
4 |
AS |
$14.08 |
$9,856 |
D/D |
(700) |
9,300 |
0 |
% |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-01-02 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-02-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-03-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-04-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-05-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-06-03 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-07-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-08-01 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
OPNT |
Opiant Pharmaceuticals In... |
Chief Scientific Officer |
|
2019-09-03 |
4 |
OE |
$9.00 |
$90,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
64 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|